CAS: 182959-28-0

YM-53601 free base is an inhibitor of squalene synthetase which suppresses lipogenic biosynthesis and lipid secretion in rodents.

YM 53601 is a non-hydrolyzable analogue of the natural statin drug pravastatin. YM 53601 inhibits cholesterol synthesis by binding to the hydroxymethylglutaryl coenzyme A reductase (HMGCR) enzyme, which is involved in the conversion of HMG-CoA to mevalonate, a precursor of cholesterol. It has been shown to inhibit the replication of viruses such as HIV and influenza in animal models. YM 53601 also inhibits cell proliferation and induces apoptosis in cancer cells, as well as inhibiting fatty acid synthase and reducing levels of fatty acids in liver cells. In humans, it has been shown that YM 53601 binds to the receptor that activates adenylate cyclase and reduces cellular levels of cAMP. This inhibition has been linked to its ability to reduce inflammation and protect against cardiovascular disease.